Literature DB >> 16538387

Catastrophic antiphospholipid syndrome related to severe ovarian hyperstimulation.

V Giner1, M R Oltra, M J Esteban, M J García-Fuster, A Salvador, J Núñez, J Redón.   

Abstract

Antiphospholipid syndrome (APS) is a cause of infertility and fetal loss. Ovarian stimulation can induce previously unknown APS. Ovarian hyperstimulation syndrome (OHS) is uncommon but potentially life-threatening, as well as catastrophic APS. A woman that simultaneously developed a severe OHS and a catastrophic APS is described in this paper. Both entities produced thrombotic cardiac and brain thrombosis. A peculiar mechanism of cardiac ischemia is also described. In spite of the life-threatening risk of this situation, the indication for preventive anti-aggregation and/or anticoagulation is not clear.

Entities:  

Mesh:

Year:  2006        PMID: 16538387     DOI: 10.1007/s10067-006-0231-4

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   3.650


  11 in total

1.  Severe complications of ovarian hyperstimulation syndrome are preventable.

Authors:  A P Murdoch; I Evbuomwan
Journal:  Hum Reprod       Date:  1999-11       Impact factor: 6.918

Review 2.  Severe OHSS: how many cases are preventable?

Authors:  P E Egbase
Journal:  Hum Reprod       Date:  2000-01       Impact factor: 6.918

Review 3.  Antiphospholipid syndrome and recurrent miscarriages.

Authors:  D Vinatier; P Dufour; M Cosson; J L Houpeau
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2001-05       Impact factor: 2.435

Review 4.  Up-date on the antiphospholipid syndrome.

Authors:  Cristina Luzzana; Maria Gerosa; Piersandro Riboldi; Pier Luigi Meroni
Journal:  J Nephrol       Date:  2002 Jul-Aug       Impact factor: 3.902

5.  Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome.

Authors:  N Guballa; L Sammaritano; S Schwartzman; J Buyon; M D Lockshin
Journal:  Arthritis Rheum       Date:  2000-03

Review 6.  [Hormonal life in systemic lupus and other connective tissue diseases].

Authors:  O Meyer
Journal:  Gynecol Obstet Fertil       Date:  2003-09

Review 7.  Peripheral arterial vasodilation hypothesis: a new insight into the pathogenesis of ovarian hyperstimulation syndrome.

Authors:  J Balasch; F Fábregues; V Arroyo
Journal:  Hum Reprod       Date:  1998-10       Impact factor: 6.918

Review 8.  Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): a review.

Authors:  Annick Delvigne; Serge Rozenberg
Journal:  Hum Reprod Update       Date:  2002 Nov-Dec       Impact factor: 15.610

9.  Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles.

Authors:  Du Le Thi Huong; Bertrand Wechsler; Danièle Vauthier-Brouzes; Pierre Duhaut; Nathalie Costedoat; Gilles Lefebvre; Jean-Charles Piette
Journal:  Semin Arthritis Rheum       Date:  2002-12       Impact factor: 5.532

10.  A case of cerebral infarct in combined antiphospholipid antibody and ovarian hyperstimulation syndrome.

Authors:  Eun-Jung Koo; Joung-Ho Rha; Byoung-Ick Lee; Myeong-Ok Kim; Choong-Kun Ha
Journal:  J Korean Med Sci       Date:  2002-08       Impact factor: 2.153

View more
  2 in total

Review 1.  Arterial thrombosis in young women after ovarian stimulation: case report and review of the literature.

Authors:  Antonio Girolami; Raffaella Scandellari; Fabiana Tezza; Dalia Paternoster; Bruno Girolami
Journal:  J Thromb Thrombolysis       Date:  2007-01-30       Impact factor: 2.300

2.  Ovarian Hyperstimulation Syndrome and Myocardial Infarction: A Systematic Review.

Authors:  Mohammed Al-Sadawi; Richi Chowdhury; Seline Asun; Justina Ray; Lina Soni; Gul Bahtiyar; Debora Ponse; Samy I McFarlane
Journal:  Int J Clin Endocrinol Metab       Date:  2018-03-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.